Innovative Medicine
healthcare areas

Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      1. Innovative Medicine /
      2. Immunology /
      3. Autoantibody diseases /
      4. Rare autoantibody

      Rare autoantibody

      Johnson & Johnson is committed to tirelessly pushing the boundaries of research to help develop innovative and transformational approaches to rare autoantibody-driven diseases, building on the ever-evolving understanding of the immune system.

      Disease areas

      Neuroscience
      June 25, 2025

      Chronic inflammatory demyelinating polyneuropathy

      Learn more
      Neuroscience
      June 25, 2025

      Myasthenia gravis

      Learn more
      Rare autoantibody
      June 25, 2025

      Warm autoimmune hemolytic anemia

      Learn more
      JJ_Photo_CorkFacility_1879.jpg

      Newsroom

      See all latest rare autoantibody news by visiting our newsroom.
      Learn more

      Featured resources

      Our work

      What is wAIHA?

      Read more
      In the news

      Rare autoantibody diseases: an innovative targeted pathway

      Read more
      Our people

      Patient Perspective: Karen Jones on the wAIHA patient experience and a path forward

      Read more
      Our people

      Listening and learning: Structuring clinical trials for patients living with warm autoimmune hemolytic anemia

      Read more
      Our work

      What is rare disease

      Read more
      Our people

      “I couldn’t speak, walk or sit.” Inside dermatomyositis, a rare autoimmune disease that attacks the muscles

      Read more
      Our work
      June 25, 2025

      Warm autoimmune hemolytic anemia (wAIHA)

      Read more